LINTHICUM, Md., June 20, 2005 (PRIMEZONE) -- Dialysis Corporation of America (Nasdaq:DCAI) announced the development of a new dialysis center in York, Pennsylvania, through an affiliation with physicians from Nephrology Associates of York.
President & CEO Stephen Everett commented, "We are thrilled to be associated with such prominent and well respected physicians in the development of what promises to be a modern, state-of-the-art center, caring for the dialysis patients of York and the surrounding areas. This new center will be our ninth in Pennsylvania, and our sixth facility under current development."
The new center will be designed with the utmost attention to patient comfort, include 24 treatment stations, and is anticipated to serve in excess of 100 patients. Construction of the facility is expected to begin within the next few months.
Dialysis Corporation of America owns and operates freestanding kidney hemodialysis centers located in Georgia, Maryland, New Jersey, Ohio, Pennsylvania, South Carolina, and Virginia, and provides in-hospital dialysis services on a contract basis to certain hospitals located in the those states. The company provides patients with their choice of a full range of quality in-center, acute or at-home hemodialysis services.
This release contains forward-looking statements that are subject to risks and uncertainties that could affect the business and prospects of the company and cause actual results and plans to differ materially from those anticipated. Those factors include, but are not limited to, maintaining continued growth and profitability, certain delays beyond the company's control with respect to future business events, the highly competitive environment in the establishment and operation of dialysis centers, the ability to develop or acquire additional dialysis facilities, whether patient bases of the company's facilities can mature to provide profitability, regulation of dialysis operations, government rate determination for Medicare reimbursement, and other risks detailed in the company's filings with the Securities and Exchange Commission ("SEC"), particularly as described in the company's registration statement on Form S-4 pending with the SEC, and in its annual report on Form 10-K for the fiscal year ended December 31, 2004. Other Dialysis Corporation of America press releases, corporate profile, corporate governance materials, quarterly and current reports, and other filings with the SEC are available on Dialysis Corporation of America's internet home page: http://www.dialysiscorporation.com.